The U.S. Government and International Family Planning & Reproductive Health Efforts
This fact sheet examines the U.S. government’s role in family planning and reproductive health (FP/RH) worldwide.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This fact sheet examines the U.S. government’s role in family planning and reproductive health (FP/RH) worldwide.
Under the Medicare Drug Price Negotiation Program, the federal government negotiates prices with drug companies for certain high-cost drugs covered under Medicare Part B and Part D. This brief provides information about several key aspects of the Medicare drug price negotiation program, with a focus on the 2028 implementation year.
This post summarizes some of the key issues related to the U.S. District Court's March 30 ruling in Braidwood Management v. Becerra, which imposes new limits on the government's ability to enforce preventive service requirements nationwide.
This survey looks at the public's health care priorities for the new Congress, including price transparency, mental health, abortion, Medicaid, and health costs. It also looks at the public's views of the main health provisions in the Inflation Reduction Act (IRA), including on Medicare drug prices.
Long-term care facility (LTCF) cases and deaths were highest in the final two months of 2020 in many states, mirroring the spike in total COVID-19 case numbers and deaths this winter.
Medicare Advantage enrollees were in a plan that included just under half (48%) of all physicians available to traditional Medicare beneficiaries in their area in 2022, on average. The limitations of provider networks illustrate one of the key tradeoffs for beneficiaries in choosing Medicare Advantage for their coverage.
This brief examines key policy challenges and issues related to distributing a COVID-19 vaccine in the U.S., including funding, supply and logistics, federal, state, and local authorities, insurance coverage, addressing racial and ethnic disparities, and communication and trust.
Government officials hope to identify one or more safe and effective COVID-19 vaccines over the next few months as part of a multi-agency effort known as Operation Warp Speed. If and when they succeed, their focus will shift to making sure people across the country can access the vaccine.
While the toll of COVID-19 on nursing home residents has been well documented, less noticed has been the experience of nonelderly people with disabilities who rely on long-term care services and supports outside of nursing homes.
This brief summarizes the information contained in the all available draft COVID-19 vaccination plans submitted by states to the CDC, focusing in particular in critical areas such as identifying critical/priority populations, identifying and recruiting providers to administer vaccines, the completeness of state-level vaccine data collection and reporting systems, and communication plans. States report widely varying levels of progress.
© 2026 KFF